Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL

被引:45
作者
Nash, RA
Storb, R
机构
[1] Fred Hutchinson Cancer Res. Center, Seattle, WA 98104
关键词
D O I
10.1016/S0952-7915(96)80085-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of a graft-versus-host reaction after allogeneic hematopoietic stem cell transplantation is an important determinant of the transplant outcome. A better understanding and improved management of the graft-versus-host reaction should allow improved prevention and treatment of graft-versus-host disease and the development of new strategies to enhance a graft-versus-leukemia effect and to decrease the incidence of leukemic relapse after transplantation.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 63 条
[1]  
BALDUZZI A, 1995, BLOOD, V86, P3247
[2]   MARROW TRANSPLANTATION FROM RELATED DONORS OTHER THAN HLA-IDENTICAL SIBLINGS [J].
BEATTY, PG ;
CLIFT, RA ;
MICKELSON, EM ;
NISPEROS, BB ;
FLOURNOY, N ;
MARTIN, PJ ;
SANDERS, JE ;
STEWART, P ;
BUCKNER, CD ;
STORB, R ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :765-771
[3]   TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BENSINGER, WI ;
WEAVER, CH ;
APPELBAUM, FR ;
ROWLEY, S ;
DEMIRER, T ;
SANDERS, J ;
STORB, R ;
BUCKNER, CD .
BLOOD, 1995, 85 (06) :1655-1658
[4]  
Billingham R E, 1966, Harvey Lect, V62, P21
[5]   Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens [J].
Blazar, BR ;
Taylor, PA ;
PanoskaltsisMortari, A ;
Barrett, TA ;
Bluestone, JA ;
Vallera, DA .
BLOOD, 1996, 87 (02) :827-837
[6]  
BLAZAR BR, 1994, BLOOD, V83, P3815
[7]   TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH METHYLPREDNISOLONE AND CYCLOSPORINE WITH OR WITHOUT AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY - A MULTICENTER PHASE-III STUDY [J].
CAHN, JY ;
BORDIGONI, P ;
TIBERGHIEN, P ;
MILPIED, N ;
BRION, A ;
WIDJENES, J ;
LIOURE, B ;
MICHEL, G ;
BURDACH, S ;
KOLB, HJ ;
LINK, H ;
VERNANT, JP ;
IFRAH, N ;
RACADOT, E ;
HERVE, P ;
EHNINGER, G .
TRANSPLANTATION, 1995, 60 (09) :939-942
[8]   CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINE AND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE [J].
CHAO, NJ ;
SCHMIDT, GM ;
NILAND, JC ;
AMYLON, MD ;
DAGIS, AC ;
LONG, GD ;
NADEMANEE, AP ;
NEGRIN, RS ;
ODONNELL, MR ;
PARKER, PM ;
SMITH, EP ;
SNYDER, DS ;
STEIN, AS ;
WONG, RM ;
BLUME, KG ;
FORMAN, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (17) :1225-1230
[9]   UNRELATED DONOR BONE-MARROW TRANSPLANTATION - INFLUENCE OF HLA-A AND HLA-B INCOMPATIBILITY ON OUTCOME [J].
DAVIES, SM ;
SHU, XO ;
BLAZER, BR ;
FILIPOVICH, AH ;
KERSEY, JH ;
KRIVIT, W ;
MCCULLOUGH, J ;
MILLER, WJ ;
RAMSAY, NKC ;
SEGALL, M ;
WAGNER, JE ;
WEISDORF, DJ ;
MCGLAVE, PB .
BLOOD, 1995, 86 (04) :1636-1642
[10]   IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN [J].
DENHAAN, JMM ;
SHERMAN, NE ;
BLOKLAND, E ;
HUCZKO, E ;
KONING, F ;
DRIJFHOUT, JW ;
SKIPPER, J ;
SHABANOWITZ, J ;
HUNT, DF ;
ENGELHARD, VH ;
GOULMY, E .
SCIENCE, 1995, 268 (5216) :1476-1480